Guidance Documents

This document (issued jointly with ED-OCR) is a resource for students and families on confronting LGBTQI+ discrimination in schools. It recognizes that in schools around the country, LGBTQI+ students have reported bullying and harassment by classmates because of their perceived or actual sexual orientation or gender identity.

The is a letter to all state attorneys general reminding them of legal provisions that protect transgender youth against discrimination, including when those youth seek gender-affirming care. The letter advises states that laws and policies that prevent individuals from receiving gender-affirming medical care may infringe on federal constitutional protections under the Equal Protection Clause and Due Process Clause of the Fourteenth Amendment. 

ATF is issuing this open letter to assist the firearms industry and the public in understanding whether a “partially complete, disassembled, or nonfunctional” frame of a Polymer80, Lone Wolf, or similar semiautomatic, striker-fired pistol (sometimes generally referred to as “Glock-type” pistols) has reached a stage of manufacture...

Debtor Education Application Instructions for Providers

Credit Counseling Application for Agencies

Email to credit counseling agencies and debtor education providers concerning updated application forms.

ATF has received requests from Federal explosives licensees and permittees (FEL/Ps) and State 
and local agencies conducting avalanche control/mitigation operations for variances to store 
explosive materials with detonators attached in remote avalanche control systems (RACS). 

This guidance document provides information regarding issuance of updated Drug Enforcement Administration (DEA) registration certificates to reflect Congress’s elimination of the X-waiver (DATA-Waiver) in the Consolidated Appropriations Act (CAA) of 2023.

This guidance document, will be sent via email to all Drug Enforcement Administration registrants to provide clarification for disposal.

Questions and answers summarizing and providing information for electronic prescription application providers (including electronic health record application providers), pharmacy application providers, and intermediaries regarding the Drug Enforcement Administration Interim Final Rule with Request for Comment “Electronic Prescriptions for Controlled Substances” (75 FR 16236, March 31, 2010).

All records for prescribing of an FDA-approved narcotic for the treatment of opioid addiction need to be kept in accordance with 21 CFR 1304.03(c), 21 CFR 1304.21(b).

This guidance document clarifies the requirement for Drug Enforcement Administration (DEA) registrant-transferors to use multiple single-sheet DEA Form 222s (order forms) when transferring schedule I or II controlled substances to a DEA registrant-transferee when the number of items being transferred exceeds the number of lines available on the order form.